Allogeneic T-Cell Therapy for Epstein-Barr Virus-Positive Posttransplant Lymphoproliferative Disease: Long-Term Follow-Up

Title
Allogeneic T-Cell Therapy for Epstein-Barr Virus-Positive Posttransplant Lymphoproliferative Disease: Long-Term Follow-Up
Authors
Keywords
-
Journal
TRANSPLANTATION
Volume 90, Issue 1, Pages 93-94
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2010-07-02
DOI
10.1097/tp.0b013e3181d7c424

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started